0.0446 USD
+0.01 (+27.43%)
0.036 USD
-0.01 (-19.28%)
ChartMill assigns a Buy % Consensus number of 83% to BTTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.36. This target is 11906.73% above the current price.
BTTX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BTTX.
In the previous month the buy percentage consensus was at a similar level.
BTTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-10 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-10 | Lake Street | Maintains | Buy -> Buy |
| 2023-04-14 | Lake Street | Maintains | Buy |
| 2023-03-31 | Chardan Capital | Maintains | Buy |
| 2022-11-15 | Chardan Capital | Maintains | Buy |
| 2022-07-29 | Chardan Capital | Maintains | Buy |
| 2021-11-24 | Chardan Capital | Initiate | Buy |
| 2021-11-10 | Cowen & Co. | Initiate | Outperform |
BETTER THERAPEUTICS INC / BTTX FAQ
What is the price target for BTTX stock?
8 analysts have analysed BTTX and the average price target is 5.36 USD. This implies a price increase of 11906.73% is expected in the next year compared to the current price of 0.0446.
Can you provide the consensus rating for BETTER THERAPEUTICS INC stock?
The consensus rating for BETTER THERAPEUTICS INC (BTTX) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for BTTX stock?
The number of analysts covering BETTER THERAPEUTICS INC (BTTX) is 8.